miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.

Lin Y, Cheng K, Wang T, Xie Q, Chen M, Chen Q, Wen Q

Open source

DOI
10.1016/j.biopha.2017.09.074
Published
2017 Nov
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2017.09.074,
  title = {miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.},
  author = {Lin Y and Cheng K and Wang T and Xie Q and Chen M and Chen Q and Wen Q},
  year = {2017},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2017.09.074},
  url = {https://doi.org/10.1016/j.biopha.2017.09.074}
}

RIS

TY  - JOUR
TI  - miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.
AU  - Lin Y
AU  - Cheng K
AU  - Wang T
AU  - Xie Q
AU  - Chen M
AU  - Chen Q
AU  - Wen Q
PY  - 2017
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2017.09.074
UR  - https://doi.org/10.1016/j.biopha.2017.09.074
ER  - 

APA

Y, L., K, C., T, W., Q, X., M, C., Q, C., & Q, W. (2017). miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2017.09.074

Source records